| Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide |
Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide |
2004659-83-8 |
| Sorafenib impurity 16/Ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate |
Sorafenib impurity 16/Ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate |
2206827-12-3 |
| Tryptophan-002 |
色氨酸标准品002 |
40856-80-2 |
| 1-((3-fluoro-4-(methylcarbamoyl)phenyl)amino)cyclobutanecarboxylic acid |
1-((3-氟-4-(甲基氨基甲酰基)苯基)氨基)环丁烷羧酸 |
2227589-22-0 |
| Fmoc-AEEA-AEEA |
FMOC-8-氨基-3,6-二噁辛酰基-8-氨基-3,6-二噁辛酸 |
560088-89-3 |
| ALPHA-AMINOISOBUTYRIC ACID T-BUTYL ESTER |
H-AIB-OT BU.盐酸盐 |
4512-32-7 |
| Tadalafil iMpurity A |
他达拉非杂质A |
951661-85-1 |
| CPI-203 |
2-氯-3-三氟甲基苯异氰酸酯 |
88330-63-6 |
| Fmoc-Arg(Pbf)-Gly-OH |
Fmoc-Arg(Pbf)-Gly-OH |
660846-80-0 |
| FMoc-D-serine Methyl ester |
FMOC-D-丝氨酸甲酯 |
874817-14-8 |
| 5-(2-fluorophenyl)-1H-Pyrrole-3-carboxylic acid |
文诺普兰杂质 |
1883595-38-7 |
| (S)-Methyl 2-((((9H-fluoren-9-yl)Methoxy)carbonyl)aMino)-6-aMinohexanoate hydrochloride |
(S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-6-氨基己酸甲酯盐酸盐 |
847658-45-1 |
| Sorafenib related coMpound 8 |
索拉非尼相关物质8 |
1431697-81-2 |
| Z-THR(TBU)-OH |
-叔丁基-L-苏氨 Z-氨基酸 |
16966-09-9 |
| Oxo Enzalutamide |
恩杂鲁胺杂质J |
1242137-18-3 |
| H-Lys(Boc)-OBzl·HCl |
N6-[叔丁氧羰基]-L-赖氨酸苄酯单盐酸盐 |
133170-57-7 |
| AC-LYS (BOC)-OH |
(S)-2-乙酰胺基-6-((叔丁氧羰基)氨基)己酸 |
23500-04-1 |
| Methyl (4-chloro-3-trifluoromethylphenyl)carbamate |
瑞格非尼杂质 |
19448-54-5 |
| Tadalafil Impurity 67 |
他达拉非杂质92 |
1863191-32-5 |
| Levosimendan-001 |
左西孟旦标准品001 |
244077-42-7 |
QQ
